Overall Assessment: The stock has been in a pronounced downtrend over the past six months, with the price declining from around $230 in early January 2026 to $189.60 by March 31, 2026, representing a 6-month change of -9.86%. This underperformance is significant relative to the broader market, as indicated by a 6-month relative strength of -7.04 against the S&P 500.

Short-term Performance: The stock has experienced severe pressure in the short term, with a 1-month decline of -9.99% and a 3-month decline of -17.18%. The most recent data shows a single-day gain of 3.11% from $183.89 to $189.60, but this follows a steep drop from a high near $242 in late January.

Current Position: The current price of $189.60 sits near the lower end of its 52-week range of $171.00 to $242.80, approximately 22% above the 52-week low. The stock's beta of 0.964 suggests it has been slightly less volatile than the market, but its recent drawdown of -25.01% highlights significant downside pressure.

Revenue & Profitability: Revenue for Q4 2025 was $6.84 billion, representing a year-over-year growth of 4.59% from the prior-year quarter. The net margin for the quarter was 17.51%, a solid figure, though quarterly profitability has shown some variability, with Q2 2025 net margin at 9.35% before recovering. The trailing twelve-month free cash flow is a robust $5.26 billion.

Financial Health: The company maintains a strong balance sheet with a debt-to-equity ratio of 0.35, indicating a conservative capital structure. Liquidity is healthy, evidenced by a current ratio of 1.87. Operating cash flow generation remains strong, supporting dividends, share repurchases, and strategic investments.

Operational Efficiency: Return on Equity (ROE) stands at 6.88%, and Return on Assets (ROA) is 4.18%. While positive, these returns have moderated from higher levels in previous years. The gross margin of 60.93% and operating margin of 20.91% demonstrate the company's ability to maintain high profitability in its core operations.